MED LIFE S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.115 RON | +0.37% |
|
+2.88% | +3.39% |
| Apr. 03 | Med Life S.A. (BVB:M) acquired an unknown majority stake in Personal Genetics Srl. | CI |
| Feb. 29 | Med Life S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
ETFs positioned on Med Life S.A.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 3.21% | 1 M€ | +14.51% | ||
| 0.00% | 117 M€ | +1.11% | - | |
| 0.00% | 7 M€ | +1.95% | - | |
| 0.00% | 34 M€ | +2.14% | - |
MedLife S.A. specializes in medical diagnosis and treatment services for enterprises and individuals. The group is active in the fields of orthopedics and traumatology, general and plastic surgery, spinal surgery, gynecology, paediatrics and maternity services.
At the end of 2021, MedLife S.A. operated 80 clinics, 11 multi- and mono-disciplinary hospitals, 34 medical laboratories (near 200 sampling centres), 17 dental clinics and 22 pharmacies located in Romania.
Calendar
2024-04-28
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
4.115
RON
Average target price
4.983
RON
Spread / Average Target
+21.10%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +3.39% | 464M | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +11.62% | 29.59B | |
| -12.71% | 16.73B | |
| -2.07% | 16.36B | |
| -31.58% | 11.77B | |
| +0.61% | 11.72B | |
| +27.44% | 11.71B | |
| -1.19% | 11.66B |
- Stock Market
- Equities
- M Stock
- Funds and ETFs Med Life S.A.
